BamSEC and AlphaSense Join Forces
Learn More

Pasithea Therapeutics Corp.

NASDAQ: KTTA    
Share price (6/11/25): $0.85    
Market cap (6/11/25): $6.320 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2022
Other Revised 10/12/22 AlloMek Therapeutics LLC, Pasithea Therapeutics Corp. - M&A Call 10/12/22 Other Revised 06/22/22 Pasithea Therapeutics Corp., Alpha-5 Integrin, LLC - M&A Call 06/22/22